Abstract

Direct visualization of point mutations in situ can be informative for studying genetic diseases and nuclear biology. We describe a direct hybridization genome imaging method with single-nucleotide sensitivity, single guide genome oligopaint via local denaturation fluorescence in situ hybridization (sgGOLDFISH), which leverages the high cleavage specificity of eSpCas9(1.1) variant combined with a rationally designed guide RNA to load a superhelicase and reveal probe binding sites through local denaturation. The guide RNA carries an intentionally introduced mismatch so that while wild-type target DNA sequence can be efficiently cleaved, a mutant sequence with an additional mismatch (e.g., caused by a point mutation) cannot be cleaved. Because sgGOLDFISH relies on genomic DNA being cleaved by Cas9 to reveal probe binding sites, the probes will only label the wild-type sequence but not the mutant sequence. Therefore, sgGOLDFISH has the sensitivity to differentiate the wild-type and mutant sequences differing by only a single base pair. Using sgGOLDFISH, we identify base-editor-modified and unmodified progeroid fibroblasts from a heterogeneous population, validate the identification through progerin immunofluorescence, and demonstrate accurate sub-nuclear localization of point mutations.

Visualisation of point mutations in situ is informative for studying genetic diseases. Here the authors report single guide genome oligopaint via local denaturation fluorescence in situ hybridisation, sgGOLDFISH, a direct hybridisation genome imaging method with single-nucleotide sensitivity.

Details

Title
Achieving single nucleotide sensitivity in direct hybridization genome imaging
Author
Wang, Yanbo 1 ; Cottle, W. Taylor 1 ; Wang, Haobo 2 ; Gavrilov, Momcilo 1   VIAFID ORCID Logo  ; Zou, Roger S. 3 ; Pham, Minh-Tam 4   VIAFID ORCID Logo  ; Yegnasubramanian, Srinivasan 5   VIAFID ORCID Logo  ; Bailey, Scott 6 ; Ha, Taekjip 7   VIAFID ORCID Logo 

 Johns Hopkins University School of Medicine, Department of Biophysics and Biophysical Chemistry, Baltimore, USA (GRID:grid.21107.35) (ISNI:0000 0001 2171 9311) 
 Johns Hopkins University School of Medicine, Bloomberg School of Public Health, Baltimore, USA (GRID:grid.21107.35) (ISNI:0000 0001 2171 9311) 
 Johns Hopkins University, Department of Biomedical Engineering, Baltimore, USA (GRID:grid.21107.35) (ISNI:0000 0001 2171 9311) 
 Johns Hopkins University School of Medicine, Department of Urology, James Buchanan Brady Urological Institute, Baltimore, USA (GRID:grid.21107.35) (ISNI:0000 0001 2171 9311); Johns Hopkins University School of Medicine, Department of Oncology, Baltimore, USA (GRID:grid.21107.35) (ISNI:0000 0001 2171 9311); Johns Hopkins University School of Medicine, Sidney Kimmel Comprehensive Cancer Center, Baltimore, USA (GRID:grid.21107.35) (ISNI:0000 0001 2171 9311); Johns Hopkins University School of Medicine, Cellular and Molecular Medicine Graduate Program, Baltimore, USA (GRID:grid.21107.35) (ISNI:0000 0001 2171 9311) 
 Johns Hopkins University School of Medicine, Department of Oncology, Baltimore, USA (GRID:grid.21107.35) (ISNI:0000 0001 2171 9311); Johns Hopkins University School of Medicine, Sidney Kimmel Comprehensive Cancer Center, Baltimore, USA (GRID:grid.21107.35) (ISNI:0000 0001 2171 9311); Johns Hopkins University School of Medicine, Cellular and Molecular Medicine Graduate Program, Baltimore, USA (GRID:grid.21107.35) (ISNI:0000 0001 2171 9311) 
 Johns Hopkins University School of Medicine, Department of Biophysics and Biophysical Chemistry, Baltimore, USA (GRID:grid.21107.35) (ISNI:0000 0001 2171 9311); Johns Hopkins University School of Medicine, Bloomberg School of Public Health, Baltimore, USA (GRID:grid.21107.35) (ISNI:0000 0001 2171 9311) 
 Johns Hopkins University School of Medicine, Department of Biophysics and Biophysical Chemistry, Baltimore, USA (GRID:grid.21107.35) (ISNI:0000 0001 2171 9311); Johns Hopkins University, Department of Biomedical Engineering, Baltimore, USA (GRID:grid.21107.35) (ISNI:0000 0001 2171 9311); Johns Hopkins University, Department of Biophysics, Baltimore, USA (GRID:grid.21107.35) (ISNI:0000 0001 2171 9311); Howard Hughes Medical Institute, Baltimore, USA (GRID:grid.413575.1) (ISNI:0000 0001 2167 1581) 
Pages
7776
Publication year
2022
Publication date
2022
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2754659817
Copyright
© The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.